Importantly, exocrine pancreatic lipase and amylase frequently increase in the plasma before overt diabetes occurs, suggesting that there is a therapeutic window for the suppression of autoimmune attacks on islets [8]. The gene discussed is PNLIP; the disease is diabetes mellitus.